Clinical Study of Impact of Different Pacing Site in Patients

Overview

At present, cardiac pacing has been widely used in the treatment of bradyarrhythmias and heart failure, which can effectively improve the survival rate of patients. With the rapid development of technology, different sites can be chosen to pace, such as right atrial appendage, the atrial septum and the right atrial wall in the atrium, His bundle, left bundle branch area, right ventricular apex, outflow tract, and left ventricular pacing via coronary vein in the ventricle. There are few studies comparing the long-term efficacy and safety of different pacing sites in daily practice. This study aims to observe the efficacy and safety of cardiac pacing at different sites in short and long term, and to compare the advantages and disadvantages of pacing at different sites.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 2025

Interventions

  • Device: Pacemaker implantation
    • Different pacing sites will be chosen according to the patients condition.

Clinical Trial Outcome Measures

Primary Measures

  • Composite of Cardiovascular death, myocardial infarction, and stroke events
    • Time Frame: 60 months
    • Composite of Cardiovascular death, myocardial infarction, and stroke events in 60 months

Participating in This Clinical Trial

Inclusion Criteria

  • Patients who received pacemaker implantation in the Second Hospital of Zhejiang Medical University by Pan Xiaohong and other surgeons. – Patients who have the ability to understand the test and can cooperate with investigators. Exclusion Criteria:

  • Patients who unable to understand or unwilling to fill in informed consent forms or follow visitors.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 100 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Second Affiliated Hospital, School of Medicine, Zhejiang University
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Contact(s)
    • Xiaohong Pan, +8613857116993, heartpanxh@zju.edu.cn

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.